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Bone tissue engineering aims to use biodegrade able scaffolds to replace 
damaged tissue. This scaffold must be gradually degraded and replaced by 
tissue as similar as possible to the original one. In this work a hybrid porous 
scaffold containing chitosan, polyvinyl alcohol and bioactive glass was 
successfully obtained and subsequently characterized by scanning electron 
microscopy. The scaffold presented satisfactory pore size range and open 
interconnected pores, which are essential for tissue ingrowth. A cytotoxicity 
assay showed that this biomaterial allows adequate cell viability, so that it was 
considered suitable for an in vivo experiment. Promising results were 
obtained with the implant of the scaffold in an experimental model of a New 
Zealand rabbit femur bone lesion. Clinical and biochemical parameters 
measured such as complete blood count, total serum proteins, albumin, 
alanine aminotransferase and aspartate aminotransferase were similar 
between animals in the control group at all time periods studied. Histological 
and histometric studies showed that the scaffold was coated with a 
cement-like substance, exhibiting many areas of mineralized structures. Very 
few osteocyte-like cells or lining-like cells were found inside the amorphous 
mineralized deposit. In vivo results allow us to consider this scaffold as a 
promising biomaterial to be applied in bone tissue engineering. 
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1. Introduction 
Synthetic three-dimensional scaffolds for application to the regeneration of bone 
tissue should present an architecture similar to bone extracellular matrix and 
provide a suitable microenvironment for cell adhesion, proliferation and diffe-
rentiation, ensuring tissue growth [1] [2]. Among other properties, these scaffolds 
should exhibit biocompatibility with the damaged tissue, interconnected pore 
network, pore size ranging from 100 to 300 µm, mechanical strength similar to 
bone tissue, and biodegradability at the rate at which tissue regenerates [3] [4]. 
Chitosan (Chi) can be considered as one of the most thoroughly investigated 
materials in recent years. The non-toxicity, high biocompatibility, and antige-
nicity of chitosan have driven its potential applications in biomedical field [5] 
[6] [7]. The biodegradability of chitosan favors its use as a biomaterial in tissue 
engineering and drug delivery systems. One aspect of this polymer that limits its 
application is its brittleness. Moreover, for tissue engineering applications, it is 
important to have a predictable kinetics of the biodegradability of the polymer. 
One way to obtain the desired properties is the use of natural or synthetic poly-
mers, either alone or blended, with grafted or crosslinked networks [7] [8] [9] 
[10]. 
In other words, the polymer blend and cross-linked polymer system may 
present a different degradation behavior under physiological fluid conditions, 
where part of the polymer network may undergo fast solvation and another por-
tion may experience slow degradation by depolymerization. Hence, chitosan 
joined to other polymers has opened a new line of research for altering or tai-
loring the property of interest. In previous works [11] [12], the approach used 
for modulating degradability and flexibility of the polymer was by blending chi-
tosan with poly(vinyl alcohol-co-vinyl acetate) (Chi/PVA blend), followed by 
chemical crosslinking with glutaraldehyde (GA). 
Mechanical strength of porous scaffolds are also crucial with respect to the 
regeneration of hard tissue such as bone, which must support a load and meet 
specific mechanical needs while stimulating bone regeneration. The most inves-
tigated approach to attain the desired levels of strength is the production of 
composites and hybrid systems [13] [14] [15] [16] in which a bioceramic phase 
is added to the degradable polymer matrix as a reinforcing agent. Bioactive 
glasses in the system SiO2-CaO-P2O5 have been largely investigated as bioactive 
ceramics to be introduced into the organic phase due to their osteoconductive 
and osteoinductive properties [17] [18]. 
In previous works [19] [20], hybrid porous scaffolds containing chitosan, 
PVA and bioactive glass were successfully obtained via a lyophilization 
method. Ch/PVA hybrids with 20% bioactive glass (w/w) cross-linked with 
glutaraldehyde showed adequate pore structure and relatively low mass loss 
during an in vitro degradation test, with preservation of their physical macro-
scopic structure, which are suitable characteristics for application in tissue en-
gineering. 
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We developed a model of bone lesion in a New Zealand rabbit femur, which 
does not resolve spontaneously, with the generation of a fibrous tissue that does 
not have the original characteristics of the tissue prior to the injury, in order to 
use it to consider the osteoregenerative potential characteristic of the scaffolds to 
be tested [21] [22] [23]. 
The present work investigates Ch/PVA containing 20% of bioactive glass 
(w/w), with a Ch:PVA mass ratio of 1:1. Pore size, morphological and in vitro 
cytotoxicity characteristics were evaluated to characterize these biomaterials. We 
also tested the biomaterial in an in vivo implant procedure in our experimetal 
model of New Zealand rabbit femur bone lesion, considering not only the im-
plant tissues but also the post-surgical clinical and biochemical studies of the 
animals. 
2. Method 
2.1. Preparation of Polymer and Bioactive Glass Precursor  
Solutions 
All reagents were supplied by Aldrich Chemical. Poly(vinyl alcohol) (PVA) solu-
tion 5.0% (w/v) was prepared by dissolving PVA (80% hydrolysis) in deionized 
water (100 mL) under mechanical stirring speed of 280rpm at 70˚C (±2˚C) for 
45 minutes. 
A solution of Chitosan (C) with high molecular weight and deacetylation 
(DD) > 75% (1% w/v) was prepared by dissolving 1 g commercial powder in 100 
ml deionized water. 2 ml acetic acid was added to the solution, and then sub-
jected to mechanical stirring for 24 hours. Bioactive glass 60 s precursor solution 
(BG) was obtained by acid hydrolysis and polycondensation of Tetraethylortho-
silicate (TEOS-(Si(OC2H5)4)), alkoxide precursor of SiO2, and Triethylphosphate 
(TEP-((C2H5O)3PO)), alkoxide precursor P2O5. Hydrolysis occurred by adding 
deionized water and nitric acid as catalyst reagents. 85 g of Calcium Nitrate 
(Ca(NO3)2∙4H2O) was then added as a precursor of CaO. The nominal composi-
tion of the bioactive glass was the following: 60% SiO2, 36% CaO; 4% P2O5. Glu-
taraldehyde solution (2.0% w/v) was prepared by diluting 25% glutaraldehyde 2 
ml in 23 ml deionized water. 
2.2. Scaffolds Production (SBG, Scaffolds of Bioactive Glass) 
The scaffolds were fabricated by mixing PVA solution with Chitosan solution 
with a CHI to PVA ratio of 1:1, as shown in Table 1, and mixing under agitation 
for 30 minutes at room temperature. The precursor solution of bioactive glass 
(20% of the total weight of the scaffold) was added and mechanical stirring was 
continued for 45 minutes. Finally, the 2% glutaraldehyde solution (3% polymer 
mass) was added and mechanical stirring continued for 15 minutes, as shown in 
Table 1. 
The resulting solution was poured into 7 ml vials with a syringe and kept at 
room temperature for 72 hours, the time required for gelation to occur. The vials  
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Table 1. Composition of scaffold. 
Scaffold CHI:PVA ratio 
Composition (%) 
Chitosan PVA VB Glutaraldehyde* 
1:1 40 40 20 3 
*In relation to polymers mass. 
 
were kept tightly closed during gelation and then frozen for 72 hours in a refri-
gerator at −20˚C. The frozen vials were immersed in liquid nitrogen for 20 mi-
nutes and then placed in the lyophilizer (Model: K105-Company Liotop-SP/Brazil) 
for 48 h with −98˚C condenser temperature and −4˚C sample collector temper-
ature. The pressure in the collector was 30 mmHg. 
2.3. Structural Characterization of Three-Dimensional SGB 
Scanning Electron Microscopy (SEM) FEI-Inspect-S50/Czech Republic was used 
for scaffold characterization. Previously, samples were frozen by liquid nitrogen 
immersion and fractured in order to obtain the internal fracture surface for 
analysis. This surface was coated with gold. 
2.4. Cytotoxicity Assay 
The cyxotoxicity assay aims to detect the potential of a material or device to 
produce lethal or sublethal effects on biological systems at the cell level. The re-
lease of toxic subproducts of the biomaterial can damage the cells or reduce the 
rate of cell culture growth. A biomaterial can be considered toxic for use in a bi-
ological system when it shows under 50% of cell viability compared to the posi-
tive control. Formazan crystals were solubilized and optical density was deter-
mined by a spectrophotometer at 595 nm. Primary culture of human fibroblasts 
at the fourth passage was plated in 24-well plates at a density of 1 × 104 cells/well. 
Cell populations were normalized with DMEM for 24 hours, after which time 
the medium was changed and the samples were placed into wells. The cylindrical 
samples were sliced into four equal parts, sterilized by irradiation at 15 kGy for 
30 minutes, and then soaked in saline solution (PBS) for 24 hours. DMEM was 
used as an experiment positive control and PBS 10× as a negative control. All 
assays were performed in triplicate (n = 3). Cells were incubated at 37˚C in a 5% 
CO2 humidified atmosphere for 72 hours. At the end of the incubation period, 
the culture medium was removed and discarded and 210 µL/well of DMEM was 
added. Then 170 µL/well of MTT solution (Invitrogen) (5 mg/ml) was added 
and the plate was incubated at 37˚C in a 5% CO2 humidified atmosphere for 2 
hours. The cells were observed under an optical microscope (MO) to display the 
formazan crystals that were solubilized by the addition of 210 µL/well of a solu-
tion of SDS 10%-HCl (0.01 M hydrochloric acid—10% of sodium dodecyl sulfate 
water) followed by incubation at 37˚C in a 5% CO2 humidified atmosphere for 
18 hours. 100 µL was transferred from each well to a 96-well plate, in triplicate, 
and optical density was measured in a spectrophotometer at 595 nm. All the 
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steps were performed in minimuml lighting conditions. Results were analyzed 
using one-way ANOVA test followed by Bonferroni test and expressed as mean 
± SEM. 
2.5. In Vivo Experiments 
2.5.1. Experimental Units 
Adult female New Zealand white rabbits with an average weight of 3.5 kg (n = 
T10) were randomly divided into two groups: C (Control) and T (treated rabbits 
with bone defects caused by surgery). Rabbits were kept in individual cages with 
food (PROVIFE, Argentina) and water ad libitum. Experimental procedures re-
garding the use of animals were approved by the Bioethics Committee of Rosario 
National University (Resolution No. 150/2015). Its regulations are in agreement 
with the well-established guidelines for animal care and manipulation to de-
crease pain and suffering of the animal, according to the 3Rs (replacement, re-
duction and refinement) and follow international laws for the care and use of 
laboratory animals. 
2.5.2. Pre-Surgical Preparation 
Antibiotic prophylaxis and anesthetic treatment were performed according to a 
procedure previously described [23]. Prior to the surgical procedure, rabbits re-
ceived antibiotic prophylaxis (cefazolin at a dose of 50 mg/kg/day, intramuscu-
larly administered). The anesthetic treatment was performed by combining three 
drugs intramuscularly administered: Ketamine Hydrochloride at 35 mg/kg/day, 
Xylazine Hydrochloride (2.0%) at 18 mg/kg, and Acepromazine Maleate (1.0%) 
at 1 mg/kg, achieving complete relaxation of the animal. The anesthetic effect 
lasted 45 - 60 minutes. 
2.5.3. Surgical Procedure 
Surgical techniques were performed in a similar way to a procedure previously 
described (38). The intervention began with a longitudinal cutaneous incision of 
4 cm in the internal lateral distal metaphysis of the femur, immediately above 
the medial condyle. Medial and lateral flaps were divided, and a non-muscular 
aponeurotic plane was opened until reaching the desired bone area. The central 
point of the perforation was marked with a bradawl, and a 6 mm diameter lesion 
was made using a drill attached to a sterile (UV) electric motor. The hemostasis 
of the lesion was performed using a sterile swab plus gauze. Then, the area was 
dried with a sterile gauze. The tested scaffolds, SGB, previously rehydrated in the 
animal`s own blood, were implanted and the wounds were sutured. The apo-
neurotic plane was first sutured using resorbable material type 3/0; the skin was 
sutured with 3/0 Nylon and disinfected with povidone-iodine. 
2.5.4. Post-Surgical Clinical Studies 
During the study period, animals were clinically monitored on a daily basis as to 
overall status, mobility and food intake. Body temperature was measured daily 
during the first week, and then weekly. Biochemical parameters were evaluated 
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by standard procedures at days 0, 2, 30 and at the end of the study; complete 
blood count, total serum proteins, albumin, alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST) were evaluated by standard procedures com-
mercial kits (Wiener lab Group, Argentina). The results were compared to the 
results obtained from control animals of the same age at each time period and 
analyzed using the Kruskall-Wallis test. 
2.5.5. Animal Euthanasia and Sample Collection 
Three months after surgery, animals were euthanized using three doses of an-
aesthesia, as previously described for other experimental models [24]. Then, fe-
murs were collected for use in different experiments aimed at assessing bone re-
generation (see below). 
3. Histological Studies 
Distal epiphysis from femurs were obtained after cuts made 4 cm above the me-
taphysis with a carborundum disc cutter (Dochem, China) using a dental drill 
under irrigation with distilled water. The implanted matrix areas were marked 
with Indian ink. The samples were subjected to decalcification using modified 
Morse solution (Okayama University Dental School) and embedded in paraffin 
following well-established protocols. Then samples were serially cut (5 µm) to 
obtain oriented tissues (ephiphysis, metaphysis with implanted matrix on the 
same plane) and stained with Hematoxylin & Eosin (H&E) and Masson’s Trich-
romic. All specimens were examined with light microscopy and evaluated by a 
single pathologist. Subsequently, another pathologist (certified by the Health 
Ministry of Argentina. license N˚ 31455) performed an independent review to 
verify microscopic observations. The reported results reflect the mutual-
ly-agreed-upon diagnoses by both pathologists. Photomicrographs were taken 
from slides of each specimen by means of an Olympus SC50 camera adapted to 
Olympus BX 43 microscope using CellSens Standard 1.17 Olympus Soft 2009-2017 
and Olympus stereo zoom SZ 51. 
Histometric Analysis: Photomicrographs were taken from slides of each 
specimen, with an Olympus SC50 camera adapted to an Olympus BX 43 micro-
scope using CellSens Standard 1.17 Olympus Soft 2009-2017. Five photos of 
each slide from the hybrid matrix area at 40× magnification, were obtained. 
The compartments chosen were: cement mineralized substance, inflammatory 
infiltrate and interstitial tissue measured with Image Pro Plus analysis system 
(Media Cybernetics, Silver Spring, MD, USA Version 4.5.0.29 for Windows 
1998/NT/2000). Values were expressed as percentages [25]. 
4. Results 
4.1. Structural Characteristics of Three-Dimensional Scaffolds  
The SGB pore morphology was analyzed by SEM and is shown in Figure 1, 
which shows a network of well-defined, open and interconnected pores with thin 
walls. Homogeneous and organized porosity was observed, pore size in the 
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Figure 1. Structural characteristics of three-dimensional scaffold by scanning electron 
microscopy (SEM). 
 
regions analyzed ranging from 64 to 234 µm in 1:1 scaffold. The scaffolds pre-
sented satisfactory pore size range, and opened interconnected pores, which are 
essential for tissue ingrowth. The presence of pores of different sizes is very im-
portant since bone tissue grows through interconnected pores in the range from 
100 to 200 µm, while cell adhesion and vascular formation occur with pores 
whose size is smaller than 100 µm. 
4.2. Cytotoxicity 
The cells cultures directly in the presence of 1:1 scaffold presented above 90% 
viability. The assay showed that this biomaterial allows adequate cell viability 
and is considered suitable for in vivo tests (Figure 2). 
4.3. Clinical and Biochemical Results 
The welfare of the animals during the first two days post-implantation was 
slightly affected, with disrupted walking, as expected. After six days, treated 
animals behaved similarly to their non-operated control counterparts. Tem-
perature values, food intake and all biochemical parameters measured in the 
treated group were similar between control animals at every time studied (n.s.d., 
p > 0.05). 
 
 
Figure 2. Cell viability for scaffolds 1:1 
compared to negative control. 
D. J. Coletta et al. 
 
 
DOI: 10.4236/jbnb.2018.94016 284 Journal of Biomaterials and Nanobiotechnology 
 
4.4. Histological Results (Figure 3: Photos 3(a), 3(b), 3(c), 3(d), 
3(e), 3(f)) 
Two areas were selected to evaluate in vivo bone biocompatibility: 1) Fe-
mur-scaffold interface experimental lesion, and 2) Scaffold. 
1) A bi-layer tissue was observed at the femur-scaffold interface formed by an 
inner thick fibrous tissue surrounded by an outer thick bone layer (Photo 3(a)). 
The new bone layer was formed by lamellar and reticular trabecular bone, thus 
forming the composite bone and located in the FEL (femoral experimental le-
sion). Close to this area, few hematopoietic tissue spaces were distinguished 
(Photo 3(b)). Micro-haemorrhage areas and micro-fragmented foreign body 
particles similar to SBG surrounded by dilated congestive blood vessels were ob-
served. 
2) Scaffold 
The SGB surface was coated with a cement-like mineralized substance, os-
teoblast-like cells were attached and extracellular matrix was produced (Photo 
3(c)), and newly formed bone anchored on the SGB surface (Photo 3(d)). Inside 
the new bone tissue formation, some bone particles probably obtained from the 
surgery process were found (Photo 3(e)). They were surface resorbed and cov-
ered by new bone formation; scattered osteogenesis was initiated inside them. 
Very few osteocyte-like cells and lining-like cells were found inside the amor-
phous mineralized deposit. Also, erythrocytes, lymphocytes and macrophages as 
well as cells debris were observed inside the scaffold (Photo 3(f)). 
4.5. Histometric Results 
Inside the SGB matrix, 64% bone-cement mineralized substance and 28% in-
flammatory exudate were produced, with 8% interstitial space (Table 2). 
5. Discussion 
The amount of mechanical stimulation performed by the scaffold depends on 
the porosity, pore size, pore distribution, architecture and mechanical properties 
of the materials. The presence of pores of different sizes is very important since 
bone tissue grows through interconnected pores in the range between 100 and 
200 μm, while cell adhesion and vascular formation occur in pores below 100 
μm. The presence of macropores (>100 μm and <500 μm) is ideal for the growth 
and adhesion of the cells and the release of the nutrients to the center of the 
newly forming tissue. The ideal pore size for the growth of bone tissue is be-
tween 75 and 250 μm [26]. 
A biomaterial can be considered toxic for use in biological systems when it 
causes under 50% of cell viability. The assay conducted in this study showed that 
this biomaterial allows adequate cell viability and is considered suitable for in 
vivo testing. 
The implantation of SGB did not cause either clinical or biochemical altera-
tions in the implanted animals, which is promising for future considerations of 
implants in other types of injuries. Certain scaffolds, when degraded, produce 
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Figure 3. (a) Low magnification photomicrograph showing the scaffold-interface (1:1), a bi-layer of fibrous and bone tissues. They 
were similar to a discontinued double capsule (black arrow). New compound bone was deposited into the FEL (femoral experi-
mental lesion) (white arrow). Inside the new bone, few hematopoietic tissue spaces showing micro-haemorrhages (black asterisk) 
were observed. H&E stained. Magnification 7.35×, Bar = 2 mm; (b) Photomicrograph from the Experimental Group showing he-
matopoietic bone marrow (white arrow) between trabeculae (black asterisk) surrounded by extended branches of blood vessels 
congestive and micro-haemorrhages (black arrow). H&E stained. Magnification 116.7×, Bar = 250 µm; (c) Photomicrograph 
showing inside and over SGB extended areas of cement mineralized substance formation (black asterisks) with few osteocyte-like 
cells (white arrow) inside and lined by osteoblast-like cells (black arrow). Macrophages, cells and material debris were observed 
(white asterisks). Masson’s Trichromic staining. Magnification 1000×, Bar = 30 µm; (d) Photomicrograph showing extended 
bone-like formation area (white asterisks) inside SGB. In the scaffold spaces, inflammatory cells and particles debris were found 
(black asterisks). Masson’s Trichromic staining. Magnification 1000×, Bar = 30 µm; (e) Photomicrograph inside SGB showing 
bone particles left from surgery, basophilic lined (black arrows) surrounded by newly formed bone (black asterisk). Outside, ce-
ment mineralized substance was found on SGB (white arrows). H&E stained. Magnification 400×, Bar = 500 µm. (f) Photomicro-
graph from implanted SGB showing cement mineralized substance deposited on matrix surface, outlined by bone-like extracellu-
lar matrix lined by osteoblast-like cells (black arrow), and spaces with inflammatory cells and rest debris (black asterisk). Masson’s 
Trichromic staining. Magnification 1000×, Bar = 30 µm. 
 
Table 2. Histometric results. 
total area Percentage of 
Cement Mineralized Substance 64 
Inflammatory Exudate 28 
Interstitial Space 8 
 
undesirable secondary effects at the metabolic level or generate hepatic altera-
tions. The fact that SGB implants did not produce any detectable alterations in-
dicates that they are biocompatible. 
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Our results showed that SGB underwent fast degradation and size decrease 
after bone implantation at FEL (femoral experimental lesion, thus showing its 
ability to be resorbed. Inside SGB, 64% of cement mineralized substance, similar 
to hydroxy carbonate apatite-like (HCA) reaction layer, was produced on its 
surface, covered by new bone-like formation with few osteocyte-like cells inside 
and lining-like cells outside, after implantation into the host tissues, as a result of 
bioactive glass component reaction [27]. 
Moreover, the cement mineralized substance showed a granulated aspect that 
could be explained by dissolution, leaching and precipitation of SGB [28]. 
The presence of 28% inflammatory cells and macrophages found in our re-
sults could be explained by Vander et al. [29] and Rodriguez Vazquez et al. [30], 
who claimed that chitosan in the manufactured scaffold and its oligomers 
stimulated macrophages activity, increasing nitric oxide, IL1 and TNF α as well 
as TGF β and PDGF. Moreover, they asserted that chitosan is hypoallergenic and 
only transiently stimulated the immune system because it was metabolized. 
Spieller et al. [31], in in vitro and in vivo studies that differed from traditional 
paradigms, found evidence that all three macrophage phenotypes (M1, M2a and 
M2c) support angiogenesis in different ways. M1 and M2c macrophages induced 
endothelial cell sprouting, while M2a macrophages promoted anastomosis. By 
modifying scaffold properties to control macrophage response, we were able to 
achieve better vascularization and manipulate bone formation. 
It could be considered that the lower values from macrophages allowed us to 
observe bone-like formation as well as osseointegration inside the scaffold of 
bone particles from the host bone, detached throught the experimental surgery 
lesion. This concept was supported by Li et al. [32] who demonstrated that an 
HCA layer obtained from bioactive glass was crucial and needed to be formed 
without being disturbed at the implant-tissue interface at the appropriate time to 
match the repair rate steps in the healing sequence of the implant site. With re-
spect to the interactions between the biomaterial and the host tissues, our results 
showed a cement-like deposit of amorphous calcium phosphate phase deposits, 
crystallizing to hydroxyapatite (HA), bonded to collagen fibrils produced by os-
teoblasts on the scaffold surface. At the scaffold-tissue interface, a thick double 
fibrous-bony capsule was formed. Nagai et al. [33] demonstrated that there are 
four types of implant-tissue response: a) If the material is toxic, the surrounding 
tissues die; b) If the material is nontoxic and biologically inactive (nearly inert), 
a fibrous tissue of variable thickness is formed; c) If the material is nontoxic and 
biologically bioactive, an interface bond is formed and d) If the material is non-
toxic and dissolves, the surrounding tissue replaces it. In this context, we con-
sider that our SGB interactions response with the tissue could be evaluated as c), 
because inside bone formation was deposited on the scaffold. 
6. Conclusion 
The scaffold obtained through the lyophilization route showed adequate pore 
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structure, presenting high porosity and suitable interconnected pores. The bio-
logical test provides evidence that it was non-toxic for the cell culture, which 
confirms that the biomaterials were adequate for the subsequent in vivo test. In 
vivo results allow us to consider SGB scaffold as a promising bone tissue 
engineering biomaterial. 
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